AI Science Tracker
EN

Combining lipidomics and machine learning to measure clinical lipids in dried blood spots

Core Metabolomics and Lipidomics Laboratory, Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Level 4 Pathology, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. · 24 Jul 2020 · medicine

Discovery

Combining lipidomics and machine learning to measure clinical lipids in dried blood spots

Source check: Source checked. Not independent scientific confirmation.

Finding: Random-forest feature selection mapped plasma lipid profiles to triglyceride, HDL, LDL and total-cholesterol concentrations in plasma (n=777) and dried-blood-spot samples (n=835). Correlations varied by lipid and were lower for some DBS measures; the authors note further work is needed before health-monitoring use.

Technology: Random-forest feature selection maps plasma lipid measurements to dried-blood-spot lipid values.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-forest feature selection maps plasma lipid measurements to dried-blood-spot lipid values.
Test and result
Random-forest feature selection maps lipid panels across 777 plasma and 835 dried-blood-spot samples; reported correlations quantify predicted triglyceride, HDL, LDL and total cholesterol.
Limitation / still unknown
The reported cohort or experimental dataset, comparator/reference and validation are specific to this case; conclusions remain bounded to that setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7381462/ · https://pubmed.ncbi.nlm.nih.gov/32710150/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.